Clinical Trials

84 enrolled

Prostatic Neoplasms

NCT03996850 2026-03-13

SPECT/CT for the Characterization of Renal Masses

Active not recruiting

102 enrolled

Kidney Neoplasms

NCT03028311 2026-03-10

Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer

12 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT04764942 2026-02-25

Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial

39 enrolled

Plasma cell

Multiple Myeloma

NCT03179904 2026-02-24

TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

17 enrolled 10 charts

Breast

Advanced Breast Carcinoma

NCT06037863 2026-02-23

Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial

168 enrolled

Prostatic Neoplasms

NCT03699995 2026-02-13

MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma

100 enrolled

Dermatologic

Melanoma, Nevus, Pigmented

NCT05497804 2026-02-03

Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial

17 enrolled

Plasma cell

Multiple Myeloma

NCT02600949 2026-01-29

Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer

117 enrolled

Phase 3 Active not recruiting

Colorectal Neoplasms

NCT04095364 2026-01-14

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

450 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00756639 2025-12-17

Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium

31 enrolled

CNSGenitourinary

Adenocarcinoma, Urinary Bladder Neoplasms, Brain Neoplasms, Carcinoma, Transitional Cell

NCT06105918 2025-12-09

Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer

6 enrolled

Biochemically Recurrent Prostate Carcinoma

NCT03896646 2025-11-21

Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)

42 enrolled

Carcinoma, Hepatocellular

NCT02068794 2025-11-18

MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Phase EARLY_PHASE1 Active not recruiting

34 enrolled 12 charts

Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05045027 2025-11-14

Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma

36 enrolled

CNS

Glioma

NCT05074264 2025-11-10

CAMPO-101

1,586 enrolled

HIV Infections

NCT05627635 2025-11-10

FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer

20 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT04821284 2025-11-04

Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer

120 enrolled

Pancreatic Neoplasms

NCT00761618 2025-10-28

Intrapleural Catheter Daily Versus Three Times a Week Drainage

257 enrolled

Thoracic

Pleural Effusion, Pleural Effusion, Malignant

NCT05779943 2025-10-27

Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer

20 enrolled 10 charts

Prostatic Neoplasms

NCT05359211 2025-09-15

NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

28 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT04014231 2025-07-18

Novel Single Wave Assessment in Measuring Cardiac Dysfunction and Metabolic Syndrome in Patients With Cancer

Active not recruiting

160 enrolled

Tumor-Agnostic

Neoplasms

NCT03944798 2024-11-22

SAFETY